SUBSCRIPTION AGREEMENTSubscription Agreement • July 2nd, 2013 • Zlato Inc. • Services-prepackaged software
Contract Type FiledJuly 2nd, 2013 Company IndustryThis Subscription Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and may be amended only by a writing executed by all parties.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2018 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 26, 2018, by and between VILACTO BIO INC., a Nevada corporation, with headquarters located at Fabriksvej 48, 4700 Naestved Denmark (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 177 Huntington Avenue, 17th Floor, Boston, MA 02115 (the “Buyer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 12th, 2018 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionREGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 26, 2018, by and between VILACTO BIO INC., a Nevada corporation (the "Company"), and AUCTUS FUND, LLC, a Delaware limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the equity purchase agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2018 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 23, 2018, is entered into by and between VILACTO BIO, INC., a Nevada corporation (the “Company”), and EMA Financial, LLC, a Delaware limited liability company (the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 12th, 2018 • Vilacto Bio Inc. • Services-prepackaged software
Contract Type FiledMarch 12th, 2018 Company IndustryThis Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).
Patent License AgreementPatent License Agreement • July 14th, 2017 • Vilacto Bio Inc. • Services-prepackaged software
Contract Type FiledJuly 14th, 2017 Company IndustryTHIS AGREEMENT (hereinafter referred to as the "Agreement") is made by and between Pharma GP ApS (hereinafter referred to as "Licensor"), a corporation with principal offices at Fabriksvej 48, 4700 Næstved, Denmark, and Vilacto Bio Inc, a limited company with principal offices at The Seagram Building, 375 Park Avenue Suite 2607, New York City NY 10152 U.S.A., (hereinafter referred to as "Licensee").
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 13th, 2018 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledNovember 13th, 2018 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT is made as of this 8th day of November, 2018 (this “Agreement”) by and among Vilacto Bio, Inc., a Nevada corporation (“Parent”), and Vilacto BioIP, LLC, a Nevada limited liability company and wholly owned subsidiary of Parent (together, “Purchaser”), on the one hand, and 9 Heroes APS, a Denmark corporation on behalf of itself and its Affiliates (as that term is defined below) (the “Seller”), on the other hand. Purchaser and Seller are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
STOCK PURCHASE AGREEMENTStock Purchase Agreement • April 20th, 2017 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledApril 20th, 2017 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”) is executed and delivered as of April 19, 2017 (the “Effective Date”), among VILACTO BIO INC., a Nevada corporation (“Buyer”); PHARMA GP APS, a Denmark corporation (the “Company”); and 9 HEROES APS, a Denmark corporation (“Stockholder”).
termination and release agreementTermination and Release Agreement • November 13th, 2018 • Vilacto Bio Inc. • Services-prepackaged software • Nevada
Contract Type FiledNovember 13th, 2018 Company Industry JurisdictionThis Termination and Release Agreement (“Agreement”) is entered into as of this 8th day of November, 2018, by and among Vilacto Bio, Inc., a Nevada corporation (the “Vilacto”), Pharma GP APS, a Denmark corporation, and its sole shareholder, 9 Heroes APS, a Denmark corporation (together “Pharma GP”).